This topic contains a solution. Click here to go to the answer

Author Question: A strength of studying the research on gender and leadership is a. The inequity in gender pay is ... (Read 71 times)

tiara099

  • Hero Member
  • *****
  • Posts: 588
A strength of studying the research on gender and leadership is
 
  a. The inequity in gender pay is a significant factor keeping women from elite leadership roles
  b. Contemporary notions of effective leadership styles is now more feminine
  c. Contemporary notions of effective leadership styles is now more androgynous
  d. The inequity in female-owned private businesses clearly impacts the gender leadership gap

Question 2

When we create a holding environment for employees we are using which adaptive leader behavior?
 
  a. Identify adaptive challenges
  b. Get on the balcony
  c. Protect leadership voices from below
  d. Regulate distress



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

iman

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

C

Answer to Question 2

D




tiara099

  • Member
  • Posts: 588
Reply 2 on: Jul 8, 2018
Great answer, keep it coming :)


Dominic

  • Member
  • Posts: 328
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The term pharmacology is derived from the Greek words pharmakon("claim, medicine, poison, or remedy") and logos ("study").

Did you know?

The heart is located in the center of the chest, with part of it tipped slightly so that it taps against the left side of the chest.

Did you know?

Nearly all drugs pass into human breast milk. How often a drug is taken influences the amount of drug that will pass into the milk. Medications taken 30 to 60 minutes before breastfeeding are likely to be at peak blood levels when the baby is nursing.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library